{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:23:00Z","timestamp":1787865780183,"version":"build-2784847793"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Department of Health Sexually Transmitted Infections and Blood Borne Viruses Research Program","award":["6VA9BPL"],"award-info":[{"award-number":["6VA9BPL"]}]},{"name":"Medical Research Future Fund Emerging Leadership 2 Fellowship","award":["APP1197177"],"award-info":[{"award-number":["APP1197177"]}]},{"DOI":"10.13039\/501100001801","name":"University of Western Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001801","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40271-025-00764-4","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T14:59:15Z","timestamp":1755874755000},"page":"83-92","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Subcutaneous Infusion of Benzathine Penicillin G Is Acceptable and Preferred Over Intramuscular Injections for Syphilis in Western Australian Sexual Health Clinic Attendees: A Mixed Methods Sub-study"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9456-5071","authenticated-orcid":false,"given":"Shakayla L.","family":"Walley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5548-7512","authenticated-orcid":false,"given":"Jane","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4075-0781","authenticated-orcid":false,"given":"Stephanie L.","family":"Enkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Kupara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Swallow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3712-8425","authenticated-orcid":false,"given":"Joseph","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7370-9139","authenticated-orcid":false,"given":"Gerard F.","family":"Hoyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5233-4438","authenticated-orcid":false,"given":"Thel K.","family":"Hla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4334-5351","authenticated-orcid":false,"given":"Laurens","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"issue":"1","key":"764_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2019.02.073","volume":"82","author":"AK Forrestel","year":"2020","unstructured":"Forrestel AK, Kovarik CL, Katz KA. Sexually acquired syphilis: historical aspects, microbiology, epidemiology, and clinical manifestations. J Am Acad Dermatol. 2020;82(1):1\u201314.","journal-title":"J Am Acad Dermatol"},{"issue":"02","key":"764_CR2","first-page":"2072","volume":"7","author":"A Jalil Abed","year":"2024","unstructured":"Jalil Abed A, Muhammad Z, Hady HH, Abed ZH, Hasan WRM, Haider Sabah D, et al. Spirochaetal diseases of human. J Curr Med Res Opin. 2024;7(02):2072\u201381.","journal-title":"J Curr Med Res Opin"},{"issue":"2","key":"764_CR3","doi-asserted-by":"publisher","first-page":"e00126","DOI":"10.1128\/cmr.00126-22","volume":"36","author":"LS Gilmour","year":"2023","unstructured":"Gilmour LS, Walls T. Congenital syphilis: a review of global epidemiology. Clin Microbiol Rev. 2023;36(2):e00126-e222.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"764_CR4","doi-asserted-by":"publisher","first-page":"e0209906","DOI":"10.1371\/journal.pone.0209906","volume":"14","author":"SV Elarrat Canto","year":"2019","unstructured":"Elarrat Canto SV, Leite Ara\u00fajo MA, Espinosa Miranda A, Paulo Cardoso AR, Freitas de Almeida RL. Fetal and infant mortality of congenital syphilis reported to the Health Information System. PLoS\u00a0One. 2019;14(1):e0209906.","journal-title":"PLoS\u00a0One"},{"issue":"5","key":"764_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.5694\/mja2.51864","volume":"218","author":"A Carter","year":"2023","unstructured":"Carter A, McManus H, Ward JS, Vickers T, Asselin J, Baillie G, et al. Infectious syphilis in women and heterosexual men in major Australian cities: sentinel surveillance data, 2011\u20132019. Med J Aust. 2023;218(5):223\u20138.","journal-title":"Med J Aust"},{"key":"764_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.31128\/AJGP-08-23-6943","volume":"53","author":"G Phua","year":"2024","unstructured":"Phua G, White C. The resurgence of syphilis in Australia. Aust J Gen Pract. 2024;53:133\u20137.","journal-title":"Aust J Gen Pract"},{"issue":"6","key":"764_CR7","doi-asserted-by":"publisher","first-page":"e417","DOI":"10.1016\/S2666-5247(22)00035-0","volume":"3","author":"ML Taouk","year":"2022","unstructured":"Taouk ML, Taiaroa G, Pasricha S, Herman S, Chow EP, Azzatto F, et al. Characterisation of Treponema pallidum lineages within the contemporary syphilis outbreak in Australia: a genomic epidemiological analysis. Lancet Microbe. 2022;3(6):e417\u201326.","journal-title":"Lancet Microbe"},{"key":"764_CR8","doi-asserted-by":"crossref","unstructured":"Do D, Rodriguez PJ, Gratzl S, Cartwright BMG, Baker C, Stucky NL. Trends in incidence of syphilis among US adults from January 2017 to October 2024. Am J Prev Med. 2025.","DOI":"10.1016\/j.amepre.2025.03.008"},{"key":"764_CR9","unstructured":"UK Health Security Agency. Tracking the syphilis epidemic in England: 2013 to 2023. Updated 12 September 2024."},{"key":"764_CR10","unstructured":"World Health Organisation. Implementing the global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022\u20132030: report on progress and gaps 2024. Geneva; 2024."},{"key":"764_CR11","unstructured":"King J, McManus H, Kwon J, Gray R, McGregor S. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2023. Kirby Institute, UNSW Sydney; 2023."},{"issue":"10","key":"764_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.5694\/j.1326-5377.2011.tb03089.x","volume":"194","author":"JS Ward","year":"2011","unstructured":"Ward JS, Guy RJ, Akre SP, Middleton MG, Giele CM, Su JY, et al. Epidemiology of syphilis in Australia: moving toward elimination of infectious syphilis from remote Aboriginal and Torres Strait Islander communities? Med J Aust. 2011;194(10):525\u20139.","journal-title":"Med J Aust"},{"key":"764_CR13","unstructured":"Care DoHaA. National syphilis surveillance quarterly report April to June 2023. Department of Health and Aged Care; 2023."},{"key":"764_CR14","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021 2021. https:\/\/www.cdc.gov\/std\/treatment-guidelines\/syphilis.htm. Accessed 22 July 2021."},{"issue":"14","key":"764_CR15","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1177\/09564624241280387","volume":"35","author":"M Kingston","year":"2024","unstructured":"Kingston M, Wilson J, Dermont S, Fifer H, Chan K, Lyall H, et al. British Association of Sexual Health and HIV (BASHH) UK guidelines for the management of syphilis in pregnancy and children 2024. Int J STD AIDS. 2024;35(14):1161\u201373.","journal-title":"Int J STD AIDS"},{"key":"764_CR16","unstructured":"Therapeutic Guidelines Limited. Treatment of neurosyphilis, ocular syphilis and otosyphilis. In: Antibiotics. Updated March 2025."},{"issue":"1","key":"764_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1071\/SH22134","volume":"20","author":"JJ Ong","year":"2023","unstructured":"Ong JJ, Bourne C, Dean JA, Ryder N, Cornelisse VJ, Murray S, et al. Australian sexually transmitted infection (STI) management guidelines for use in primary care 2022 update. Sex Health. 2023;20(1):1\u20138.","journal-title":"Sex Health"},{"issue":"5","key":"764_CR18","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1111\/jan.14782","volume":"77","author":"T Basak","year":"2021","unstructured":"Basak T, Demirtas A, Yorubulut SM. Virtual reality and distraction cards to reduce pain during intramuscular benzathine penicillin injection procedure in adults: a randomized controlled trial. J Adv Nurs. 2021;77(5):2511\u20138.","journal-title":"J Adv Nurs"},{"issue":"1","key":"764_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/1753-6405.12737","volume":"42","author":"AG Mitchell","year":"2018","unstructured":"Mitchell AG, Belton S, Johnston V, Read C, Scrine C, Ralph AP. Aboriginal children and penicillin injections for rheumatic fever: how much of a problem is injection pain? Aust N Z J Public Health. 2018;42(1):46\u201351.","journal-title":"Aust N Z J Public Health"},{"issue":"2","key":"764_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/jpc.12400","volume":"50","author":"K Russell","year":"2014","unstructured":"Russell K, Nicholson R, Naidu R. Reducing the pain of intramuscular benzathine penicillin injections in the rheumatic fever population of Counties Manukau District Health Board. J Paediatr Child Health. 2014;50(2):112\u20137.","journal-title":"J Paediatr Child Health"},{"key":"764_CR21","unstructured":"Collaboration for Evidence RaIiPH. Late latent syphilis treatment: clinical perspectives of the current three-dose benzathine penicillin G regimen and the implementation of a single-dose regimen. Bentley: CERIPH; 2024."},{"issue":"5","key":"764_CR22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/OLQ.0000000000001775","volume":"50","author":"E Mangone","year":"2023","unstructured":"Mangone E, Bell J, Khurana R, Taylor MM. Treatment completion with three-dose series of benzathine penicillin among people diagnosed with late latent and unknown duration of syphilis, Maricopa Country, Arizona. Sex Trans Dis. 2023;50(5):298\u2013303.","journal-title":"Sex Trans Dis"},{"key":"764_CR23","first-page":"204993612412659","volume":"11","author":"A Clarkson-During","year":"2024","unstructured":"Clarkson-During A, Almirol E, Eller D, Hazra A, Stanford KA. Risk factors for treatment non-completion among patients with syphilis. Ther Adv Infect Dis. 2024;11:20499361241265940.","journal-title":"Ther Adv Infect Dis"},{"issue":"3","key":"764_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/sti.2004.011999","volume":"81","author":"S Mullick","year":"2005","unstructured":"Mullick S, Beksinksa M, Msomi S. Treatment for syphilis in antenatal care: compliance with the three dose standard treatment regimen. Sex Transm Infect. 2005;81(3):220\u20132.","journal-title":"Sex Transm Infect."},{"issue":"12","key":"764_CR25","doi-asserted-by":"publisher","first-page":"e00962","DOI":"10.1128\/aac.00962-23","volume":"67","author":"J Kado","year":"2023","unstructured":"Kado J, Salman S, Hla TK, Enkel S, Henderson R, Hand RM, et al. Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic study. Antimicrob Agents Chemother. 2023;67(12):e00962-e1023.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"764_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0302493","volume":"19","author":"J Cooper","year":"2024","unstructured":"Cooper J, Enkel SL, Moodley D, Dobinson H, Andersen E, Kado JH, et al. \u201cHurts less, lasts longer\u201d; a qualitative study on experiences of young people receiving high-dose subcutaneous injections of benzathine penicillin G to prevent rheumatic heart disease in New Zealand. PLoS\u00a0One. 2024;19(5): e0302493.","journal-title":"PLoS\u00a0One"},{"key":"764_CR27","doi-asserted-by":"publisher","unstructured":"Hla TK, Salman S, Kado J, Moore BR, Manning L. Could late-latent syphilis be treated with a single subcutaneous infusion of long-acting penicillin? Sex Health 2024;21(2):SH24003. https:\/\/doi.org\/10.1071\/SH24003","DOI":"10.1071\/SH24003"},{"key":"764_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285037","author":"SL Enkel","year":"2023","unstructured":"Enkel SL, Kado J, Hla TK, Salman S, Bennett J, Anderson A, et al. Qualitative assessment of healthy volunteer experience receiving subcutaneous infusions of high-dose benzathine penicillin G (SCIP) provides insights into design of late phase clinical studies. PLoS\u00a0One. 2023. https:\/\/doi.org\/10.1371\/journal.pone.0285037.","journal-title":"PLoS\u00a0One"},{"key":"764_CR29","unstructured":"\u2018One injection vs. three\u2019: clinical evaluation of a single, high dose subcutaneous infusion of benzathine penicillin G for treatment of syphilis (SCIP Syphilis) [Internet]. https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12622000349741. Accessed 30 Oct 2024."},{"issue":"4","key":"764_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/14737167.2019.1612242","volume":"19","author":"Y Jackson","year":"2019","unstructured":"Jackson Y, Janssen E, Fischer R, Beaverson K, Loftus J, Betteridge K, et al. The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care management. Expert Rev Pharmacoecon Outcomes Res. 2019;19(4):383\u201396.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"764_CR31","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S153875","author":"J-H Tsai","year":"2018","unstructured":"Tsai J-H, Janssen E, Bridges JF. Research as an event: a novel approach to promote patient-focused drug development. Patient Prefer Adherence. 2018. https:\/\/doi.org\/10.2147\/PPA.S153875.","journal-title":"Patient Prefer Adherence"},{"key":"764_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2023-002450","author":"J Ilievski","year":"2024","unstructured":"Ilievski J, Mirams O, Trowman R, Barr RK, Manning L. Patient preferences for prophylactic regimens requiring regular injections in children and adolescents: a systematic review and thematic analysis. BMJ Paediatr Open. 2024. https:\/\/doi.org\/10.1136\/bmjpo-2023-002450.","journal-title":"BMJ Paediatr Open"},{"issue":"6","key":"764_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"16","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;16(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"key":"764_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41687-018-0053-6","volume":"2","author":"S Safikhani","year":"2018","unstructured":"Safikhani S, Gries KS, Trudeau JJ, Reasner D, R\u00fcdell K, Coons SJ, et al. Response scale selection in adult pain measures: results from a literature review. J Patient Rep Outcomes. 2018;2:1\u20139.","journal-title":"J Patient Rep Outcomes"},{"issue":"2","key":"764_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/120347540100500202","volume":"5","author":"MM Chren","year":"2001","unstructured":"Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001;5(2):105\u201310.","journal-title":"J Cutan Med Surg"},{"issue":"9","key":"764_CR36","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S2215-0366(19)30296-2","volume":"6","author":"V Braun","year":"2019","unstructured":"Braun V, Clarke V. Novel insights into patients\u2019 life-worlds: the value of qualitative research. Lancet Psychiatr. 2019;6(9):720\u20131.","journal-title":"Lancet Psychiatr"},{"issue":"4","key":"764_CR37","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1197\/aemj.10.4.390","volume":"10","author":"PE Bijur","year":"2003","unstructured":"Bijur PE, Latimer CT, Gallagher EJ. Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Acad Emerg Med. 2003;10(4):390\u20132.","journal-title":"Acad Emerg Med"},{"issue":"2","key":"764_CR38","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.det.2011.11.003","volume":"30","author":"MM Chren","year":"2012","unstructured":"Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012;30(2):231\u20136.","journal-title":"Dermatol Clin"},{"key":"764_CR39","first-page":"923","volume":"9","author":"J Jin","year":"2015","unstructured":"Jin J, Zhu L, Chen M, Xu H, Wang H, Feng X, et al. The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection. Patient Prefer Adherence. 2015;9:923\u201342.","journal-title":"Patient Prefer Adherence"},{"key":"764_CR40","unstructured":"RHD Action. Global Status of BPG Report. RHD Action; 2016."},{"issue":"5","key":"764_CR41","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1177\/17407745211015924","volume":"18","author":"C Zahren","year":"2021","unstructured":"Zahren C, Harvey S, Weekes L, Bradshaw C, Butala R, Andrews J, et al. Clinical trials site recruitment optimisation: guidance from clinical trials: impact and quality. Clin Trials. 2021;18(5):594\u2013605.","journal-title":"Clin Trials"},{"issue":"2","key":"764_CR42","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s10461-016-1598-0","volume":"21","author":"A Mey","year":"2017","unstructured":"Mey A, Plummer D, Dukie S, Rogers GD, O\u2019Sullivan M, Domberelli A. Motivations and barriers to treatment uptake and adherence among people living with HIV in Australia: a mixed-methods systematic review. AIDS Behav. 2017;21(2):352\u201385.","journal-title":"AIDS Behav"},{"issue":"10","key":"764_CR43","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1093\/jac\/dkaa282","volume":"75","author":"JH Kado","year":"2020","unstructured":"Kado JH, Salman S, Henderson R, Hand R, Wyber R, Page-Sharp M, et al. Subcutaneous administration of benzathine benzylpenicillin G has favourable pharmacokinetic characteristics for the prevention of rheumatic heart disease compared with intramuscular injection: a randomized, crossover, population pharmacokinetic study in healthy adult volunteers. J Antimicrob Chemother. 2020;75(10):2951\u20139.","journal-title":"J Antimicrob Chemother"}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-025-00764-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40271-025-00764-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-025-00764-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T21:03:10Z","timestamp":1768165390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40271-025-00764-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["764"],"URL":"https:\/\/doi.org\/10.1007\/s40271-025-00764-4","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"value":"1178-1653","type":"print"},{"value":"1178-1661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"28 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open Access funding enabled and organized by CAUL and its Member Institutions. This study was funded through the Department of Health Sexually Transmitted Infections and Blood Borne Viruses research program grant (6VA9BPL) and Medical Research Future Fund Emerging Leadership 2 fellowship grant awarded to L.M. (APP1197177).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For participant privacy, raw interview data are not available. Interview transcripts contain potentially identifying and sensitive information. Enquiries related to this qualitative sub-study may be addressed to South Metropolitan Health Service (RGS0000005165) and the University of Notre Dame (2023-118) Human Research Ethics Committees (HREC) at smhs.hrec@health.wa.gov.au and res.ethics@nd.edu.au.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Ethics approval for this mixed methods sub-study was received from the South Metropolitan Health Service (RGS0000005165) and the University of Notre Dame Australia (2023-118) Human Research Ethics Committees.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Conceptualisation: L.M. and T.H. Data curation: S.W., A.K., S.S., S.E., J.O., and T.H. Data analysis: S.W., S.E., J.O., and L.M. Writing, review and editing: S.W., T.H., S.E., A.K., S.S., J.C., G.H., J.O., and L.M.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}